Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

This study has been completed.

Study NCT00035880. Last updated on June 23, 2005. Information provided by Abgenix

Please refer to this study by its ClinicalTrials.gov identifier: NCT00035880

Locations


United States, California
	Abgenix, Inc
	Fremont, California, United States, 94555

Sponsors and Collaborators

Abgenix

Sangstat Medical Corporation